1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Anal Neoplasm: new trials by email Literature Review of Anal Neoplasm trials Research Report on Anal Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors vobramitamab duocarmazine 2.0 mg (Arm A), vobramitamab duocarmazine 2.7 mg (Arm B), vobramitamab duocarmazine - Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer | Phase 2 | Terminated | MacroGenics | 192 | 2023-06-13 | 2026-02-09 |
| VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 VGX-3100, CELLECTRA™ 5PSP - Anal Neoplasm | Phase 2 | Completed | Inovio Pharmaceuticals | 23 | 2018-05-15 | 2023-07-14 |
Anus Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Small Cell (1) · Melanoma (1) · Prostatic Neoplasms, Castration-Resistant (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Squamous Intraepithelial Lesions (1)
Anus Diseases (2) · Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Rectal Diseases (2) · Rectal Neoplasms (2) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1)
VGX-3100 (1) · abiraterone (1) · enzalutamide (1)
Inovio Pharmaceuticals (1) · MacroGenics (1)
United States (2) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Jeffrey Skolnik, MD (1) · Liudmila Schafer, M.D. (1)